Abstract
Salmonella enterica servovar Typhimurium is capable of targeting, colonizing, and eliciting growth suppression of tumors in mice. We examined the effects of mutations on this anticancer phenotype in two Salmonella virulence gene clusters. Salmonella pathogenicity island (SPI)-1 genes promote systemic invasion from the intestine, whereas SPI-2 genes support systemic survival within macrophages and other cells. Disabling SPI-1 (prgH−) strongly reduced invasion in vitro, but had no effect on tumor growth suppression in vivo. However, disabling SPI-2 (ssaT−) ablated tumor growth suppression. In addition to ssaT−, mutations in SPI-2 genes sseA, sseB, sseC, sscA, and ssrA also eliminated antitumor activity, whereas mutations in sseF or sseG yielded partial loss of function. Impaired tumor amplification was seen in three SPI-2 mutants tested after intravenous or intratumoral injection. A SPI-2− strain was unable to suppress tumor growth in CD18-deficient mice with defective macrophages and neutrophils, suggesting that loss of tumor growth suppression in wild-type mice by SPI-2 mutants was not solely a function of increased susceptibility to immune attack. Thus, SPI-2 is essential for the Salmonella antitumor effects, perhaps by aiding bacterial amplification within tumors, and is the first identified genetic system for this Salmonella phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pawelek J, Low KB, Bermudes D . Tumor-targeted Salmonella as a novel anti-cancer vector Cancer Res 1997 57: 4537–4544
Bermudes D, Low B, Pawelek J . Tumor-targeted Salmonella: highly selective delivery vectors In: Habib N, ed Cancer Gene Therapy Plenum, New York 1999 415–432
Clairmont C, Lee KC, Pike J et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium J Infect Dis 2000 181: 1996–2002
Bermudes D, Low B, Pawelek J . Tumor-targeted Salmonella: strain development and expression of the HSV TK effector gene In: Walther W and Stein U, eds Gene Therapy: Methods and Protocols vol. 35: Totowa, NJ: Humana Press 2000 419–436
Li Z, Lang W, Runyan J et al. Tissue distribution and in vivo expression of cytosine deaminase by TAPET-CD, a genetically engineered strain of Salmonella typhimurium as an anti-tumor vector Am Assoc Cancer Res 2001 42: 687
Lin SL, Spinka TL, Le TX et al. Tumor-directed delivery and amplification of tumor-necrosis factor-α by attenuated Salmonella typhimurium Clin Cancer Res 1999 5: 3822s
Low KB, Ittensohn M, Le T et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo Nat Biotechnol 1999 17: 37–41
Finlay BB, Brumell JH . Salmonella interactions with host cells: in vitro to in vivo Philos Trans R Soc Lond, Biol Sci 2000 355: 623–631
Salama NR, Falkow S . Genomic clues for defining bacterial pathogenicity Microbes Infect 1999 1: 615–619
Bowe R, Lipps CJ, Tsolis RM, Groisman E, Heffron F, Kusters JG . At least four percent of the Salmonella typhimurium genome is required for fatal infection of mice Infect Immun 1998 66: 3372–3377
Groisman EA, Ochman H . How Salmonella became a pathogen Trends Microbiol 1997 5: 343–349
Galan JE, Curtiss RD . Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells Proc Natl Acad Sci USA 1989 86: 6383–6387
Lucas RL, Lee CA . Unravelling the mysteries of virulence gene regulation in Salmonella typhimurium Mol Microbiol 2000 36: 1024–1033
Hensel M . Salmonella pathogenicity island 2 Mol Microbiol 2000 36: 1015–1023
Hensel M et al. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages Mol Microbiol 1998 30: 163–174
Shea JE, Hensel M, Gleeson C, Holden DW . Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium Proc Natl Acad Sci USA 1996 93: 2593–2597
Ochman H, Soncini FC, Solomon F, Groisman EA . Identification of a pathogenicity island required for Salmonella survival in host cells Proc Natl Acad Sci USA 1996 93: 7800–7804
Cirillo DM, Valdivia RH, Monack DM, Falkow S . Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival Mol Microbiol 1998 30: 175–188
Behlau I, Miller SI . A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells J Bacteriol 1998 175: 4475–4484
Davis RW, Botstein D, Roth JR . Advanced Bacterial Genetics Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1980
Bajaj V, Lucas RL, Hwang C, Lee CA . Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression Mol Microbiol 1996 22: 703–714
Lee CA, Falkow S . Isolation of hyperinvasive mutants of Salmonella Methods Enzymol 1994 236: 531–545
Wilson RW, Ballantyne CM, Smith CW et al. Gene targeting yields a CD18− mutant mouse for study of inflammation J Immunol 1993 151: 1571–1578
Daniel WW . Biostatistics: A Foundation for Analysis in the Health Sciences 7th edn New York: Wiley 1999 627
Lostroh CP, Bajaj V, Lee CA . The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI 1 Mol Microbiol 2000 37: 300–315
Hensel M . Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella pathogenicity island 2 Mol Microbiol 1997 24: 155–167
Deiwick J, Nikolaus T, Shea JE, Gleeson C, Holden DW, Hensel M . Mutations in Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and resistance to antimicrobial agents J Bacteriol 1998 180: 4775–4780
Vazquez-Torres A, Jones-Carson J, Baumlert AJ et al. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes Nature 1999 401: 804–808
Uchiya K-I, Barbieri MA, Funato K, Shah AH, Stahl PD, Groisman EA . A Salmonella virulence protein that inhibits cellular trafficking EMBO J 1999 18: 3924–3933
Martinez-Lorenzo MJ, Meresse S, de Chastellier C, Gorvel JP . Unusual intracellular trafficking of Salmonella typhimurium in human melanoma cells Cell Microbiol 2001 3: 407–416
Beuzon CR, Banks G, Deiwick J, Hensel M, Holden DW . pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium Mol Microbiol 1999 33: 806–816
Acknowledgements
We thank David Bermudes, Jean Bolognia, and Mario Sznol for helpful discussions. Supported by a Grant from Vion Pharmaceuticals (New Haven, CT).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pawelek, J., Sodi, S., Chakraborty, A. et al. Salmonella pathogenicity island-2 and anticancer activity in mice. Cancer Gene Ther 9, 813–818 (2002). https://doi.org/10.1038/sj.cgt.7700501
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700501
Keywords
This article is cited by
-
The motility regulator flhDC drives intracellular accumulation and tumor colonization of Salmonella
Journal for ImmunoTherapy of Cancer (2019)
-
Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy
Nature Communications (2019)
-
Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration
Scientific Reports (2016)
-
Engineered Salmonella typhimurium expressing E7 fusion protein, derived from human papillomavirus, inhibits tumor growth in cervical tumor-bearing mice
Biotechnology Letters (2014)
-
An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth
Cancer Gene Therapy (2010)